[1]种 萌,牛亚芳,马 鑫,等.基于Web of Science数据库对新冠疫苗副作用相关文献的计量学分析[J].医学信息,2022,35(07):10-14.[doi:10.3969/j.issn.1006-1959.2022.07.003]
　CHONG Meng,NIU Ya-fang,MA Xin,et al.Bibliometric Analysis of the Literature Related to the Side Effects of COVID-19 Vaccine Based on the Web of Science Database[J].Medical Information,2022,35(07):10-14.[doi:10.3969/j.issn.1006-1959.2022.07.003]
点击复制

基于Web of Science数据库对新冠疫苗副作用相关文献的计量学分析()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
35卷
期数:
2022年07期
页码:
10-14
栏目:
医学数据科学
出版日期:
2022-04-01

文章信息/Info

Title:
Bibliometric Analysis of the Literature Related to the Side Effects of COVID-19 Vaccine Based on the Web of Science Database
文章编号:
1006-1959（2022）07-0010-05
作者:
种 萌; 牛亚芳; 马 鑫; 等
（1.兰州大学第二医院重症医学三科，甘肃 兰州 730030；2.兰州大学第二临床医学院，甘肃 兰州 730030）
Author(s):
CHONG Meng; NIU Ya-fang; MA Xin; et al.
(1.The Third Department of Critical Medicine,the Second Hospital of Lanzhou University,Lanzhou 730030,Gansu,China;2.The Second Clinical Medical College of Lanzhou University,Lanzhou 730030,Gansu,China)
关键词:
新冠疫苗; 副作用; 新型冠状病毒肺炎
Keywords:
COVID-19 vaccine; Side effects; Coronavirus disease 2019
分类号:
R186
DOI:
10.3969/j.issn.1006-1959.2022.07.003
文献标志码:
A
摘要:
目的 通过文献计量学方法分析新冠疫苗副作用相关研究文献，了解国内外新冠疫苗相关的前沿问题。方法 计算机检索2020年1月-2021年8月Web of Science核心合集数据库（WOSCC）中发表的新冠疫苗副作用的相关文献，分析文献的发表国家、作者、期刊、机构、关键词、文献引用情况及被引频次等情况。结果 共纳入文献489篇，Harvard Med Sch为最大的发文机构，NEW ENGL J MED为文献被引用次数最多的期刊，美国是新冠疫苗副作用相关文献的主要产出国家，李敬新和朱凤才为发文量最多的作者；该领域主要的研究热点为新冠病毒感染、预先暴露、副作用、严重新冠病毒感染、人类健康体系、进展前景、疫苗观望态度、其他人类冠状病毒感染等。结论 目前新冠疫苗副作用的相关研究总体呈增长趋势，随着新冠疫苗接种人群越来越多，其有效性及安全性将会愈发受到重视，医务工作者应投入更多的研究，深化国际间合作，为未来的研究奠定基础。
Abstract:
Objective To analyze the literature on the side effects of new coronal vaccines by bibliometrics, and to understand the frontier issues related to COVID-19 vaccine in China and abroad.Methods The literatures on side effects of COVID-19 vaccine published in the Web of Science Core Collection Database (WOSCC) from January 2020 to August 2021 were retrieved by computer. The publication countries, authors, journals, institutions, keywords, citations and citation frequencies of the literatures were analyzed.Results A total of 489 articles were included. Harvard Med Sch was the largest publishing institution, NEW ENGL J MED was the most cited journal, the United States was the main producing country of COVID-19 vaccine side effects related literature, and LI Jing-xin and ZHU Feng-cai were the authors with the largest number of publications. The main research hotspots in this field were novel coronavirus infection, pre-exposure, side effects, severe new coronavirus infection, human health system, progress prospect, vaccine watch attitude, and other human coronavirus infection.Conclusion Currently, studies on the side effects of COVID-19 vaccine are on the increase. With the increasing number of people vaccinated with COVID-19 vaccine, more attention will be paid to its effectiveness and safety. Medical workers should invest in more research and deepen international cooperation to lay the foundation for future research.

参考文献/References:

[1]Hu B,Guo H,Zhou P,et al.Characteristics of SARS-CoV-2 and COVID-19[J].Nat Rev Microbiol,2021,19(3):141-154.[2]Cui J,Li F,Shi ZL.Origin and evolution of pathogenic coronaviruses[J].Nat Rev Microbiol,2019,17(3):181-192.[3]Wang J,Pan L,Tang S,et al.Mask use during COVID-19: A risk adjusted strategy[J].Environ Pollut,2020,266(Pt 1):115099.[4]Hong LX,Lin A,He ZB,et al.Mask wearing in pre-symptomatic patients prevents SARS-CoV-2 transmission: An epidemiological analysis[J].Travel Med Infect Dis,2020(36):101803.[5]Knoll MD,Wonodi C.Oxford-AstraZeneca COVID-19 vaccine efficacy[J].Lancet,2021,397(10269):72-74.[6]CDC COVID-19 Response Team,Food and Drug Administration.Allergic Reactions Including Anaphylaxis After Receipt of the First Dose of Pfizer-BioNTech COVID-19 Vaccine - United States, December 14-23, 2020[J].MMWR Morb Mortal Wkly Rep,2021,70(2):46-51.[7]Belmonte JL,Moreno-Guerrero AJ,L?仵pez-Nú?觡ez JA,et al.Analysis of the Productive, Structural, and Dynamic Development of Augmented Reality in Higher Education Research on the Web of Science[J].Applied Sciences,2019,9(24):5306.[8]陈悦,陈超美,刘则渊,等.CiteSpace 知识图谱的方法论功能[J].科学学研究,2015,33(2):242-253.[9]Polack FP,Thomas SJ,Kitchin N,et al.C4591001 Clinical Trial Group. Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine[J].N Engl J Med,2020,383(27):2603-2615.[10]Huang C,Wang Y,Li X,et al.Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China[J].Lancet,2020,395(10223):497-506.[11]Sharma O,Sultan AA,Ding H,et al.A review of the progress and challenges of developing a vaccine for COVID-19[J].Front Immunol,2020(11):585354.[12]Rubin EJ,Longo DL.SARS-CoV-2 Vaccination - An Ounce (Actually, Much Less) of Prevention[J].N Engl J Med,2020,383(27):2677-2678.[13]Weinberg GA,Szilagyi PG.Vaccine epidemiology: efficacy, effectiveness, and the translational research roadmap[J].J Infect Dis,2010(201):1607-1610.[14]Vesikari T,Matson DO,Dennehy P,et al.Rotavirus Efficacy and Safety Trial (REST) Study Team. Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine[J].N Engl J Med,2006,354(1):23-33.[15]Dhama K,Sharun K,Tiwari R,et al.COVID-19, an emerging coronavirus infection: advances and prospects in designing and developing vaccines, immunotherapeutics, and therapeutics[J].Hum Vaccin Immunother,2020,16(6):1232-1238.[16]赵蓉英,许丽敏.从文献计量学到网络计量学嬗变的可视化分析[J].情报科学,2011,29(7):975-983.[17]李杰.CiteSpace中文版指南(2015)[EB /OL].https://www.docin.com /p-1254677223.html,2015,2015-04-26/2020-06-23.[18]Zhu FC,Hu SY,Hong Y,et al.Efficacy, immunogenicity and safety of the AS04-HPV-16/18 vaccine in Chinese women aged 18-25 years: End-of-study results from a phase II/III, randomised, controlled trial[J].Cancer Med,2019,8(14):6195-6211.

更新日期/Last Update: 1900-01-01